- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ruxolitinib
Total 381 results
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Washington University School of MedicineIncyte CorporationWithdrawnCOVID-19
-
Abramson Cancer Center of the University of PennsylvaniaCompletedEstrogen-receptor Positive Invasive Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Azienda USL Toscana Nord OvestAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera Universitaria... and other collaboratorsUnknownSevere Acute Respiratory Syndrome Coronavirus 2
-
University of CologneCompletedRecurrent Classical Hodgkin LymphomaGermany
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
University of MonastirCompletedSepsis | Chronic Obstructive Pulmonary Disease | Antibiotics
-
Incyte CorporationCompletedA Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisAtopic DermatitisUnited States, Canada
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States
-
DSM Nutritional Products, Inc.CompletedGut MicrobiotaNetherlands
-
Maastricht University Medical CenterCompleted
-
Prof. Dr. Nikolas von BubnoffClinical Trials Unit FreiburgTerminated
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
Incyte CorporationTerminatedMyeloproliferative Neoplasm (MPN)United States, Italy
-
Novartis PharmaceuticalsCompletedAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFPrimary Myelofibrosis (MF) | Post-Polycythemia Vera (PV) MF | Post-Essential Thrombocythemia (ET) MFTaiwan, Japan, Korea, Republic of, China
-
Novartis PharmaceuticalsCompletedMyelofibrosisFrance, United Kingdom, Belgium, Germany, Netherlands, Italy, Austria, Spain, Sweden
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 Infection | Pf Subclinical ParasitemiaKenya, Malawi, Uganda
-
Novartis PharmaceuticalsCompletedPolycythemia VeraGermany, Belgium, France, Austria, Canada, Thailand, Norway, Bulgaria, Portugal, Chile, Mexico, Sweden
-
Northwestern UniversityCompleted
-
M.D. Anderson Cancer CenterHelsinn Healthcare SACompletedMyeloproliferative DiseasesUnited States
-
Margherita MaffioliUnknown
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaGermany
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
St. Petersburg State Pavlov Medical UniversityMinistry of Health, Russian FederationCompleted
-
St. Petersburg State Pavlov Medical UniversityCompletedPrimary Myelofibrosis | Myeloproliferative DisordersRussian Federation
-
Yonsei UniversityCompleted
-
Incyte CorporationCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States
-
Incyte CorporationTerminatedPancreatic CancerUnited States, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Korea, Republic of, Canada, New Zealand, Australia, Thailand
-
John MascarenhasNational Cancer Institute (NCI); Novartis; Incyte Corporation; Myeloproliferative...TerminatedPrimary Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Canada, United Kingdom
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
Incyte CorporationNovartis PharmaceuticalsCompletedPolycythemia VeraUnited States, Canada, France, Italy, United Kingdom, China, Belgium, Germany, Spain, Turkey, Japan, Australia, Korea, Republic of, Netherlands, Russian Federation, Argentina, Thailand, Hungary
-
John MascarenhasNational Cancer Institute (NCI); Incyte Corporation; Myeloproliferative Disorders-Research...CompletedMyeloproliferative NeoplasmsUnited States
-
Kantonsspital AarauNovartis; University Hospital, Basel, Switzerland; Clinical Trial Unit, University...TerminatedCancer CachexiaSwitzerland
-
PfizerTerminatedPrimary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia MyelofibrosisUnited States, Japan
-
Memorial Sloan Kettering Cancer CenterIncyte CorporationCompleted
-
Capital Research Institute of PediatricsUnknown
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...Unknown
-
The Lymphoma Academic Research OrganisationNovartisCompletedHodgkin's LymphomaFrance, Belgium
-
Washington University School of MedicineIncyte CorporationNo longer available
-
Hoffmann-La RocheCompletedMyelofibrosisItaly, United States, Canada, Germany
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Canada, Australia
-
Incyte CorporationCompletedPolycythemia Vera | Thrombocytosis | MyelofibrosisUnited States
-
Incyte CorporationTerminatedBreast CancerUnited States, France, United Kingdom, Spain, Italy, Portugal